FDA.reportPublic FDA data

Boruzu 3.5 MG per 1.4 ML Injection

RxCUI
2693996
RxNorm name
Boruzu 3.5 MG per 1.4 ML Injection
Display name
Boruzu 3.5 MG per 1.4 ML Injection
Full name
Boruzu 3.5 MG per 1.4 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:18

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BORUZUBORTEZOMIBAmneal Pharmaceuticals LLCb92628dd-fa09-4c3a-b6a3-66426025807c2025-07-05Warnings, Adverse reactionsExact identifier
rxcui: 2693996

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b92628dd-fa09-4c3a-b6a3-66426025807cBORUZU 3.5 MG in 1.4 ML Injection [PSN] · 1.4 ML bortezomib 2.5 MG/ML Injection [Boruzu] [SBD] · 1.4 ML Boruzu 2.5 MG/ML Injection [SY] · Boruzu 3.5 MG per 1.4 ML Injection [SY]42These highlights do not include all the information needed to use BORUZU safely and effectively. See full prescribing information for BORUZU. BORUZU ® (bortezomib injection), for subcutaneous or intravenous use Initial U.S. Approval: 200320250705